Palmitic Acid

Palmitic Acid

SCHEMBL4798201

CCCCCCCCCCCCCCCC(=O)O.CCCCCCCCCCCCCCCC(=O)O.Cc1ncc(CO)c(CO)c1O

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.63
▸ HSD17B10 Q99714 2/20 0.63
▸ KDM4E B2RXH2 2/20 0.63
▸ HPGD P15428 2/20 0.63
▸ LMNA P02545 2/20 0.51
▸ HDAC1 Q13547 1/20 0.46
▸ GPR84 Q9NQS5 7/20 0.45
▸ PPARG P37231 7/20 0.45
▸ PPARD Q03181 7/20 0.45
▸ PPARA Q07869 7/20 0.45
▸ HDAC11 Q96DB2 5/20 0.45
▸ TSHR P16473 4/20 0.45
▸ PTPN1 P18031 3/20 0.45
▸ TLR2 O60603 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ FABP4 P15090 2/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ SLC22A6 Q4U2R8 1/20 0.45
▸ SLC22A8 Q8TCC7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridoxine SCHEMBL483437 1.00 ALDH1A1 (0.63) ALDH1A1HSD17B10KDM4EHPGDLMNA
Dodecanoate SCHEMBL29381594 1.00 ALDH1A1 (0.63) ALDH1A1HSD17B10KDM4EHPGDLMNA
Decanoic Acid SCHEMBL30694319 1.00 ALDH1A1 (0.63) ALDH1A1HSD17B10KDM4EHPGDLMNA
Palmitic Acid SCHEMBL29361257 1.00 ALDH1A1 (0.63) ALDH1A1HSD17B10KDM4EHPGDLMNA
Palmitic Acid SCHEMBL516266 1.00 ALDH1A1 (0.63) ALDH1A1HSD17B10KDM4EHPGDLMNA
Palmitic Acid SCHEMBL15540470 0.99 ALDH1A1 (0.61) ALDH1A1HSD17B10KDM4EHPGDLMNA
Azelaic Acid SCHEMBL5981734 0.95 KDM4E (0.71) ALDH1A1HSD17B10KDM4EHPGDLMNA
Pyridoxine SCHEMBL28806638 0.93 KDM4E (0.73) ALDH1A1HSD17B10KDM4EHPGDLMNA
Pyridoxine SCHEMBL31514964 0.87 KDM4E (0.77) ALDH1A1HSD17B10KDM4EHPGDLMNA
Pyridoxine SCHEMBL405402 0.81 KDM4E (0.83) ALDH1A1HSD17B10KDM4EHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3101407-B1 KIT AND METHOD FOR ELECTRON MICROSCOPE OBSERVATION JAPAN SCIENCE & TECH AGENCY (JP) 2023-03-08 — — EP disclosed
US-10128078-B2 Protective agent for electron microscopic observation of biological sample in water-containing state, kit for electron microscopic observation, methods for observation, diagnosis, evaluation, and quantification by electron microscope, and sample stage JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2018-11-13 — — US disclosed
EP-2755225-B1 ELECTRON-MICROSCOPIC EXAMINATION METHOD FOR EXAMINING A LIVING BIOLOGICAL SAMPLE JAPAN SCIENCE & TECH AGENCY (JP) 2017-05-10 — — EP disclosed
US-9557253-B2 Electron microscopic observation method for observing biological sample in shape as it is, and composition for evaporation suppression under vacuum, scanning electron microscope, and transmission electron microscope used in the method JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2017-01-31 — — US disclosed
EP-3101407-A1 PROTECTANT FOR ELECTRON MICROSCOPE OBSERVATION OF HYDRATED BIOLOGICAL SAMPLE, KIT FOR ELECTRON MICROSCOPE OBSERVATION, METHOD FOR OBSERVATION, DIAGNOSIS, EVALUATION, OR QUANTIFICATION BY ELECTRON MICROSCOPE, AND SAMPLE STAGE Japan Science And Technology Agency (JP) 2016-12-07 — — EP disclosed
US-20160343539-A1 PROTECTIVE AGENT FOR ELECTRON MICROSCOPIC OBSERVATION OF BIOLOGICAL SAMPLE IN WATER-CONTAINING STATE, KIT FOR ELECTRON MICROSCOPIC OBSERVATION, METHODS FOR OBSERVATION, DIAGNOSIS, EVALUATION, AND QUANTIFICATION BY ELECTRON MICROSCOPE, AND SAMPLE STAGE JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2016-11-24 — — US disclosed
US-20140227734-A1 ELECTRON MICROSCOPIC OBSERVATION METHOD FOR OBSERVING BIOLOGICAL SAMPLE IN SHAPE AS IT IS, AND COMPOSITION FOR EVAPORATION SUPPRESSION UNDER VACUUM, SCANNING ELECTRON MICROSCOPE, AND TRANSMISSION ELECTRON MICROSCOPE USED IN THE METHOD JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2014-08-14 — — US disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 — — EP disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 — — US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR ALDH1A1 1854/4885HSD17B10 1707/4885KDM4E 1101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback